These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 35154598)

  • 1. Circulating non-coding RNAs as potential diagnostic biomarkers in liver diseases.
    Mokhtari F; Mohebbi SR; Sharifian A; Ramandi M; Razzaghi MR
    Gastroenterol Hepatol Bed Bench; 2021; 14(Suppl1):S10-S23. PubMed ID: 35154598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNAs in non-alcoholic fatty liver disease: Progress and perspectives.
    Hochreuter MY; Dall M; Treebak JT; Barrès R
    Mol Metab; 2022 Nov; 65():101581. PubMed ID: 36028120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Micro RNAs as Emerging Therapeutic Targets in Liver Diseases.
    Latief U; Tung GK; Per TS; Kaur M; Thakur S; Singh H; Jain SK
    Curr Protein Pept Sci; 2022; 23(6):369-383. PubMed ID: 35899959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating MicroRNAs as a Tool for Diagnosis of Liver Disease Progression in People Living with HIV-1.
    Martinez MA; Tural C; Franco S
    Viruses; 2022 May; 14(6):. PubMed ID: 35746590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating miRNAs: Potential Novel Biomarkers for Hepatopathology Progression and Diagnosis of Schistosomiasis Japonica in Two Murine Models.
    Cai P; Gobert GN; You H; Duke M; McManus DP
    PLoS Negl Trop Dis; 2015; 9(7):e0003965. PubMed ID: 26230095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating MicroRNAs and Long Non-coding RNAs as Potential Diagnostic Biomarkers for Parkinson's Disease.
    Yang Y; Li Y; Yang H; Guo J; Li N
    Front Mol Neurosci; 2021; 14():631553. PubMed ID: 33762908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-coding RNAs in hepatitis C-induced hepatocellular carcinoma: dysregulation and implications for early detection, diagnosis and therapy.
    Hou W; Bonkovsky HL
    World J Gastroenterol; 2013 Nov; 19(44):7836-45. PubMed ID: 24307777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Profiling circulating microRNAs in patients with cirrhosis and acute-on-chronic liver failure.
    Blaya D; Pose E; Coll M; Lozano JJ; Graupera I; Schierwagen R; Jansen C; Castro P; Fernandez S; Sidorova J; Vasa-Nicotera M; Solà E; Caballería J; Trebicka J; Ginès P; Sancho-Bru P
    JHEP Rep; 2021 Apr; 3(2):100233. PubMed ID: 33665588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of miRNAs in the Pathophysiology of Liver Diseases and Toxicity.
    Schueller F; Roy S; Vucur M; Trautwein C; Luedde T; Roderburg C
    Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29337905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNAs as regulators, biomarkers and therapeutic targets in liver diseases.
    Wang X; He Y; Mackowiak B; Gao B
    Gut; 2021 Apr; 70(4):784-795. PubMed ID: 33127832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-Coding RNAs as Potential Novel Biomarkers for Early Diagnosis of Hepatic Insulin Resistance.
    Pielok A; Marycz K
    Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32545342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating microRNAs: new biomarkers in diagnosis, prognosis and treatment of cancer (review).
    Allegra A; Alonci A; Campo S; Penna G; Petrungaro A; Gerace D; Musolino C
    Int J Oncol; 2012 Dec; 41(6):1897-912. PubMed ID: 23026890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating microRNAs as predictive biomarkers for liver disease progression of chronic hepatitis C (genotype-4) Egyptian patients.
    El-Hefny M; Fouad S; Hussein T; Abdel-Hameed R; Effat H; Mohamed H; Abdel Wahab AH
    J Med Virol; 2019 Jan; 91(1):93-101. PubMed ID: 30133717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating microRNAs and long non-coding RNAs in gastric cancer diagnosis: An update and review.
    Huang YK; Yu JC
    World J Gastroenterol; 2015 Sep; 21(34):9863-86. PubMed ID: 26379393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating microRNAs as diagnostic and prognostic tools for hepatocellular carcinoma.
    Zhang YC; Xu Z; Zhang TF; Wang YL
    World J Gastroenterol; 2015 Sep; 21(34):9853-62. PubMed ID: 26379392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNAs: Small molecules with big impacts in liver injury.
    Abdel Halim AS; Rudayni HA; Chaudhary AA; Ali MAM
    J Cell Physiol; 2023 Jan; 238(1):32-69. PubMed ID: 36317692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating liver-specific microRNAs as noninvasive diagnostic biomarkers of hepatic diseases in human.
    Musaddaq G; Shahzad N; Ashraf MA; Arshad MI
    Biomarkers; 2019 Mar; 24(2):103-109. PubMed ID: 30252499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA and Cardiovascular Diseases.
    Çakmak HA; Demir M
    Balkan Med J; 2020 Feb; 37(2):60-71. PubMed ID: 32018347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased number of circulating exosomes and their microRNA cargos are potential novel biomarkers in alcoholic hepatitis.
    Momen-Heravi F; Saha B; Kodys K; Catalano D; Satishchandran A; Szabo G
    J Transl Med; 2015 Aug; 13():261. PubMed ID: 26264599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating microRNAs as Potential Biomarkers in Pancreatic Cancer-Advances and Challenges.
    Seyhan AA
    Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.